Rebecca Sayer
Adult Health · New Iberia, LANPI 1750604625
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 266 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 51.1% of the total. Reporting peaked in 2023 at $1,397 and has fallen 88.5% since, to $161 in 2025.
Across 266 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$581
- Johnson & Johnson$352
- QOL Medical, LLC$246
- Ardelyx, Inc.$157
- Intercept Pharmaceuticals, Inc.$112
- plus $727 from 17 others
What the payments were for
- Food & beverage$4,28196%
- Education$1634%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 132 | $2,270 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 38 | $581 |
| Johnson & Johnson | 22 | $352 |
| QOL Medical, LLC | 14 | $246 |
| Ardelyx, Inc. | 9 | $157 |
| Intercept Pharmaceuticals, Inc. | 8 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $85 |
| Celltrion USA Inc. | 4 | $82 |
| Pfizer | 4 | $66 |
| Sanofi | 2 | $59 |
| Redhill Biopharma Inc. | 4 | $57 |
| Lilly USA, LLC | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Braintree Laboratories, Inc. | 3 | $43 |
| Merck | 3 | $42 |
| Nestle Healthcare Nutrition Inc. | 2 | $33 |
| Boehringer Ingelheim | 2 | $31 |
| Bristol Myers Squibb | 2 | $30 |
| Amgen | 1 | $26 |
| Gilead | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Mylan Institutional Inc. | 1 | $15 |
How this compares
$4,444 in reported general payments places this provider in the 75th percentile of 203 adult health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 23 | $123,756 |
| LinzessLinaclotide | 94 | $56,724 |
| Dexlansoprazole DrDexlansoprazole | 68 | $16,578 |
| MotegrityPrucalopride Succinate | 21 | $11,198 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 125 | $7,894 |
| TrulancePlecanatide | 12 | $6,459 |
| MovantikNaloxegol Oxalate | 13 | $5,371 |
| Lubiprostone | 44 | $4,512 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 13 | $2,205 |
| Famotidine | 220 | $2,039 |
| Pantoprazole Sodium | 339 | $1,987 |
| Esomeprazole Magnesium | 14 | $1,603 |
| Lactulose | 51 | $1,385 |
| CholestyramineCholestyramine (With Sugar) | 15 | $1,356 |
| Colestipol Hcl | 18 | $1,060 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $2,270 | $180,480117 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $85 | $11,19821 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $581 | $6,45912 claims |
| Redhill Biopharma Inc.Movantik | $57 | $5,37113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 203 adult health providers in Louisiana.
Other adult health in New Iberia
- Jeannine LafranceNew Iberia$3K
- Joan SmithBaton Rouge$121K
- Fiona WinterbottomNew Orleans$51K
- Damika HarmonLake Charles$27K
- Jade CarrereHouma$23K
- Deborah SmithBaton Rouge$18K
- Tanisha SmithBaton Rouge$17K
- Eva Marina StaffordBaton Rouge$15K
- Dustin DenicolaBaton Rouge$14K
- Melissa LamaPonchatoula$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.